COVID-19: IgG seroconversion under intensive glucocorticoid treatment in a  high-risk patient with minimal change disease.

COVID-19: IgG seroconversion under intensive glucocorticoid treatment in a high-risk patient with minimal change disease. Wien Klin Wochenschr. 2020 Dec 08;: Authors: Eder M, Strassl R, Kläger J, Aigner C, Thalhammer F, Kikić Ž Abstract In this case report we present a rare case of a patient with multiple risk factors for severe coronavirus disease (COVID 19) in whom intensive glucocorticoid treatment due to incipient nephrotic syndrome coincided with SARS-CoV‑2 infection. Despite this high baseline risk profile and the use of glucocorticoids the patient developed only mild disease including IgG SARS-CoV‑2 seroconversion. PMID: 33289854 [PubMed - as supplied by publisher]
Source: Wiener Klinische Wochenschrift - Category: General Medicine Authors: Tags: Wien Klin Wochenschr Source Type: research